Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics
NCT01420003 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2015-03-20
Summary
The purpose of this study is to characterize the time course of B cell activation after allergen challenge, and more specifically measure the M1 prime related biomarkers.
Conditions
- Atopic Asthma
Interventions
- PROCEDURE
-
Bone Marrow Aspiration
3 per study
- PROCEDURE
-
Tonsil Biopsy
Optional upon completion of study
Sponsors & Collaborators
-
Genentech, Inc.
collaborator INDUSTRY -
Hamilton Health Sciences Corporation
lead OTHER
Principal Investigators
-
Gail M Gauvreau, PhD · McMaster Health Sciences
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2014-07-31
- Completion
- 2014-07-31
Countries
- Canada
Study Locations
More Related Trials
-
Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma
NCT01501942 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma
NCT00267202 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists
NCT00670930 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase Ib Study of RC1416 Injection
NCT06911866 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of in Vitro Blocking the Common Beta Chain on Cell Viability in Asthma
NCT01759849 ·Status: COMPLETED
-
T Cell Effector and Regulatory Mechanisms in Asthma
NCT01612936 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
NCT01366521 ·Status: COMPLETED ·Phase: PHASE2
-
Airway Immune Response to Allergens (Use Lay Language Here)
NCT04619017 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma
NCT01370317 ·Status: COMPLETED ·Phase: PHASE1
-
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
NCT01711593 ·Status: COMPLETED ·Phase: PHASE1
-
Lung-Resident Memory Th2 Cells in Asthma
NCT03455959 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma
NCT00507130 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
NCT00595491 ·Status: RECRUITING ·Phase: PHASE1
-
Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild Asthma
NCT00725582 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
NCT06637371 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma
NCT02512900 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Allergen Challenge on Inflammation Induced by Toll-like Receptor Stimulation in a Nasal Model
NCT01204060 ·Status: UNKNOWN ·Phase: NA
-
Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood
NCT00116311 ·Status: UNKNOWN
-
Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
NCT01362621 ·Status: COMPLETED
-
Imaging Study of the Lungs During an Allergic Asthma Attack
NCT01547286 ·Status: COMPLETED ·Phase: NA
-
Multiple Dose ASM8 in Mild Asthmatics
NCT00264966 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids
NCT02087644 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma
NCT00546143 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma
NCT00870584 ·Status: COMPLETED ·Phase: PHASE4